Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Dow
QuintilesIMS
Cerilliant
McKesson
Harvard Business School
Cipla
Fish and Richardson
Daiichi Sankyo

Generated: May 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 062290

« Back to Dashboard

NDA 062290 describes ERYDERM, which is a drug marketed by Arbor Pharms Inc and is included in one NDA. Additional details are available on the ERYDERM profile page.

The generic ingredient in ERYDERM is erythromycin. There are one hundred and two drug master file entries for this compound. Thirty-seven suppliers are listed for this compound. Additional details are available on the erythromycin profile page.
Summary for 062290
Tradename:ERYDERM
Applicant:Arbor Pharms Inc
Ingredient:erythromycin
Patents:0
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 062290

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:SOLUTION;TOPICALStrength2%
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Cerilliant
US Department of Justice
Fish and Richardson
QuintilesIMS
Moodys
Daiichi Sankyo
AstraZeneca
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.